DE60322882D1 - T zell-subpopulation zur regelung der darmimmunität - Google Patents

T zell-subpopulation zur regelung der darmimmunität

Info

Publication number
DE60322882D1
DE60322882D1 DE60322882T DE60322882T DE60322882D1 DE 60322882 D1 DE60322882 D1 DE 60322882D1 DE 60322882 T DE60322882 T DE 60322882T DE 60322882 T DE60322882 T DE 60322882T DE 60322882 D1 DE60322882 D1 DE 60322882D1
Authority
DE
Germany
Prior art keywords
cells
polypeptide
activity
vivo
regulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322882T
Other languages
English (en)
Inventor
Olivier Lantz
Emmanuel Treiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Institut Curie filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of DE60322882D1 publication Critical patent/DE60322882D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/505Cells of the immune system involving T-cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DE60322882T 2002-05-14 2003-05-13 T zell-subpopulation zur regelung der darmimmunität Expired - Lifetime DE60322882D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/143,822 US7829289B2 (en) 2002-05-14 2002-05-14 T cell subpopulation regulating gut immunity
PCT/EP2003/004992 WO2003095606A2 (en) 2002-05-14 2003-05-13 A t cell subpopulation regulating gut immunity

Publications (1)

Publication Number Publication Date
DE60322882D1 true DE60322882D1 (de) 2008-09-25

Family

ID=29418471

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322882T Expired - Lifetime DE60322882D1 (de) 2002-05-14 2003-05-13 T zell-subpopulation zur regelung der darmimmunität

Country Status (8)

Country Link
US (1) US7829289B2 (de)
EP (1) EP1504261B1 (de)
AT (1) ATE404865T1 (de)
AU (1) AU2003240631A1 (de)
DE (1) DE60322882D1 (de)
DK (1) DK1504261T3 (de)
ES (1) ES2312782T3 (de)
WO (1) WO2003095606A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7829289B2 (en) * 2002-05-14 2010-11-09 Institut National De La Sante Et De Recherche Medicale T cell subpopulation regulating gut immunity
WO2008087219A1 (en) * 2007-01-19 2008-07-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for regulating t cell activity
JP2011503104A (ja) 2007-11-09 2011-01-27 カリフォルニア インスティテュート オブ テクノロジー 免疫調節化合物ならびに関連組成物および方法
US20100275282A1 (en) * 2009-04-23 2010-10-28 Round June L Methods and systems for identifying immunomodulatory substances
ES2694100T3 (es) 2010-04-07 2018-12-18 California Institute Of Technology Vehículo para distribuir un compuesto en una membrana mucosa y composiciones, procedimientos y sistemas relacionados
WO2013009945A1 (en) 2011-07-12 2013-01-17 The Brigham And Women's Hospital, Inc. Lipid-containing psa compositions, methods of isolation and methods of use thereof
US10011602B2 (en) 2012-07-06 2018-07-03 The University Of Melbourne Immunological reagents and uses therefor
EP2994161B1 (de) 2013-05-10 2020-10-28 California Institute of Technology Probiotische prävention und behandlung von dickdarmkrebs
US11331335B2 (en) 2015-06-10 2022-05-17 California Institute Of Technology Sepsis treatment and related compositions methods and systems
WO2017031431A1 (en) 2015-08-19 2017-02-23 President And Fellows Of Harvard College Lipidated psa compositions and methods
EP3484441A4 (de) 2016-07-15 2020-03-18 President and Fellows of Harvard College Glycolipidzusammensetzungen und verfahren zur verwendung
AU2018231405B2 (en) * 2017-03-07 2024-02-08 Universität Basel MR1 restricted T cell receptors for cancer immunotherapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7829289B2 (en) * 2002-05-14 2010-11-09 Institut National De La Sante Et De Recherche Medicale T cell subpopulation regulating gut immunity

Also Published As

Publication number Publication date
DK1504261T3 (da) 2009-01-05
WO2003095606A2 (en) 2003-11-20
AU2003240631A1 (en) 2003-11-11
ES2312782T3 (es) 2009-03-01
US7829289B2 (en) 2010-11-09
WO2003095606A3 (en) 2004-03-25
EP1504261A2 (de) 2005-02-09
US20030215808A1 (en) 2003-11-20
ATE404865T1 (de) 2008-08-15
AU2003240631A8 (en) 2003-11-11
EP1504261B1 (de) 2008-08-13

Similar Documents

Publication Publication Date Title
Roubelakis et al. Amniotic fluid and amniotic membrane stem cells: marker discovery
Wagner et al. Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins
Machida et al. Primary rat muscle progenitor cells have decreased proliferation and myotube formation during passages
DE60322882D1 (de) T zell-subpopulation zur regelung der darmimmunität
Unzai et al. Quantitative analyses of the projection of individual neurons from the midline thalamic nuclei to the striosome and matrix compartments of the rat striatum
Jiménez Fernández et al. Strategies to target ISG15 and USP18 toward therapeutic applications
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
RU2008126743A (ru) Способ получения фармацевтической композиции
WO2007084342A3 (en) Codon optimi zed il- 15 and il- 15r-alpha genes for expression in mammalian cells
SE0201863D0 (en) Cell penetrating peptides
WO1998031818A3 (en) Tace-like and matrilysin-like polypeptides
CA2338541A1 (en) Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
WO2006116181A3 (en) Regulatory t cell mediator proteins and uses thereof
Souček et al. Growth/differentiation factor-15 is an abundant cytokine in human seminal plasma
AU5911499A (en) Leptin induced genes
Calvigioni et al. Functional differentiation of cholecystokinin-containing interneurons destined for the cerebral cortex
Siletz et al. Transcription factor networks in invasion-promoting breast carcinoma-associated fibroblasts
Alter et al. IL-6 in the infarcted heart is preferentially formed by fibroblasts and modulated by purinergic signaling
ATE464320T1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
Sternberg et al. Seven diverse human embryonic stem cell-derived chondrogenic clonal embryonic progenitor cell lines display site-specific cell fates
Stiubea-Cohen et al. Effect of irradiation on cell transcriptome and proteome of rat submandibular salivary glands
Pepin et al. Assessing the cGAS-cGAMP-STING activity of cancer cells
CY1109289T1 (el) Αλληλεπιδραση κινασων μεκκ1 σερινης θρεονινης με το σχετιζομενο με το fha forkhead πεδιο της πρωτεϊνης 1 (mif 1)
WO2004003158A3 (en) Methods and compositions for modulating and detecting wisp activity
CA2435375A1 (en) Mammalian tumor susceptibility gene products and their uses

Legal Events

Date Code Title Description
8364 No opposition during term of opposition